130 related articles for article (PubMed ID: 2856872)
1. Vasoactive intestinal peptide increases prolactin messenger ribonucleic acid content in GH3 cells.
Carrillo AJ; Pool TB; Sharp ZD
Endocrinology; 1985 Jan; 116(1):202-6. PubMed ID: 2856872
[TBL] [Abstract][Full Text] [Related]
2. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
3. Autoparacrine action of vasoactive intestinal peptide on dopaminergic control of prolactin secretion.
Balsa JA; Sánchez-Franco F; Lorenzo MJ; Pazos F; Lara JI; Cacicedo L
Endocrinology; 1996 Feb; 137(2):508-13. PubMed ID: 8593796
[TBL] [Abstract][Full Text] [Related]
4. Pituitary prolactin messenger ribonucleic acid levels in incubating and laying hens: effects of manipulating plasma levels of vasoactive intestinal polypeptide.
Talbot RT; Hanks MC; Sterling RJ; Sang HM; Sharp PJ
Endocrinology; 1991 Jul; 129(1):496-502. PubMed ID: 2055202
[TBL] [Abstract][Full Text] [Related]
5. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal polypeptide antiserum affects rat prolactin mRNA in 40-day but not 110-day diethylstilbestrol-induced prolactinoma tissue.
Maas DL; Meier DA; Wahle JS; Martinson DR; Hagen TC
Mol Cell Neurosci; 1994 Apr; 5(2):182-8. PubMed ID: 8032686
[TBL] [Abstract][Full Text] [Related]
7. Vasoactive intestinal polypeptide and thyrotropin-releasing hormone stimulate newly synthesized, not stored, prolactin.
Maas DL; Arnaout MA; Martinson DR; Erdmann MD; Hagen TC
Endocrinology; 1991 Feb; 128(2):1015-20. PubMed ID: 1899215
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
9. Coculturing posterior pituitary and GH3 cells: dramatic stimulation of prolactin gene expression.
Corcia A; Steinmetz R; Liu JW; Ben-Jonathan N
Endocrinology; 1993 Jan; 132(1):80-5. PubMed ID: 8419149
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase-C mediates chicken vasoactive intestinal peptide stimulated prolactin secretion and gene expression in turkey primary pituitary cells.
Sun S; el Halawani ME
Gen Comp Endocrinol; 1995 Sep; 99(3):289-97. PubMed ID: 8536940
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
12. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
13. [The effects of gastrin-releasing peptide (GRP) and vasoactive intestinal polypeptide (VIP) on the prolactin (PRL) gene transcription of pitutitary PRL releasing tumor of rat].
Di AK; Shan HM; Huang MY; Xu RK
Sheng Li Xue Bao; 1997 Feb; 49(1):79-87. PubMed ID: 9812837
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide (VIP) stimulates prolactin (PRL) release and cAMP production in a rat pituitary cell line (GH3/B6). Additive effects of VIP and TRH on PRL release.
Gourdji D; Bataille D; Vauclin N; Grouselle D; Rosselin G; Tixier-Vidal A
FEBS Lett; 1979 Aug; 104(1):165-8. PubMed ID: 89971
[No Abstract] [Full Text] [Related]
15. Effects of hypophysiotropic factors on growth hormone and prolactin secretion from somatotroph adenomas in culture.
Ishibashi M; Yamaji T
J Clin Endocrinol Metab; 1985 May; 60(5):985-93. PubMed ID: 2858494
[TBL] [Abstract][Full Text] [Related]
16. Energy metabolism in rat pituitary tumors during stimulation of prolactin by vasoactive intestinal polypeptide and thyrotropin-releasing hormone: a study with nuclear magnetic resonance spectroscopy.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Maxwell R; Griffiths JR
Endocrinology; 1986 Dec; 119(6):2574-9. PubMed ID: 3096693
[TBL] [Abstract][Full Text] [Related]
17. Vasoactive intestinal peptide stimulates prolactin mRNA expression in turkey pituitary cells: effects of dopaminergic drugs.
Xu M; Proudman JA; Pitts GR; Wong EA; Foster DN; el Halawani ME
Proc Soc Exp Biol Med; 1996 May; 212(1):52-62. PubMed ID: 8618952
[TBL] [Abstract][Full Text] [Related]
18. Vasoactive intestinal peptide causes a calcium-dependent stimulation of prolactin secretion in GH4C1 cells.
Bjøro T; Haug E; Sand O; Gautvik KM
Mol Cell Endocrinol; 1984 Aug; 37(1):41-50. PubMed ID: 6432604
[TBL] [Abstract][Full Text] [Related]
19. Differential involvement of protein kinase C in basal versus acetylcholine-regulated prolactin secretion in rat anterior pituitary cells during aging.
Pu HF; Liu TC
J Cell Biochem; 2002; 86(2):268-76. PubMed ID: 12111996
[TBL] [Abstract][Full Text] [Related]
20. Insulin regulates prolactin secretion and messenger ribonucleic acid levels in pituitary cells.
Prager D; Yamashita S; Melmed S
Endocrinology; 1988 Jun; 122(6):2946-52. PubMed ID: 3286229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
